Amedeo Smart

Free Medical Literature Service

 

Amedeo

Asthma
  Free Subscription

Articles published in
Ann Allergy Asthma Immunol
    November 2025
  1. SUZAKI I, Tanaka A, Teguchi S, Teguchi Y, et al
    Dupilumab achieves clinical remission of comorbid asthma in patients with high-burden eosinophilic chronic rhinosinusitis.
    Ann Allergy Asthma Immunol. 2025 Nov 21:S1081-1206(25)01357.
    >> Share

    October 2025
  2. FELESZKO W, Caminati M, Gern JE, Johnston SL, et al
    Effect of tezepelumab on asthma exacerbations co-occurring with infection-attributed acute respiratory illnesses.
    Ann Allergy Asthma Immunol. 2025 Oct 8:S1081-1206(25)01201.
    >> Share

  3. LAIDLAW TM
    Aspirin-exacerbated respiratory disease in the era of biologics.
    Ann Allergy Asthma Immunol. 2025;135:366-373.
    >> Share

    September 2025
  4. KUNG TJ, Weng CF, Wu SC, Lin FJ, et al
    Comparative Effectiveness of Fixed-Dose ICS/LABA Therapy in Adult Patients with Asthma.
    Ann Allergy Asthma Immunol. 2025 Sep 29:S1081-1206(25)01205.
    >> Share

  5. THOMPSON D, Visness CM, Wood RA, O'Connor GT, et al
    Associations between body weight, asthma burden, and T2 inflammation among under-resourced children.
    Ann Allergy Asthma Immunol. 2025 Sep 27:S1081-1206(25)01204.
    >> Share

  6. AMADO C, Lopez-Padilla D, Mendez R, Martinez-Garcia MA, et al
    AIRWAY OVERLAP SYNDROMES WITH ASTHMA.
    Ann Allergy Asthma Immunol. 2025 Sep 18:S1081-1206(25)01168.
    >> Share

  7. TIOTIU A, Pilette C, Bagnasco D, Bondi B, et al
    Comparative analysis of biologics' effects on lung function parameters in severe asthma.
    Ann Allergy Asthma Immunol. 2025 Sep 6:S1081-1206(25)01156.
    >> Share

  8. JHANG YS, Chang HC, Gau SY
    Risk of asthma in US adults with COVID-19 in real-world settings.
    Ann Allergy Asthma Immunol. 2025;135:347-348.
    >> Share

  9. ABDELKADER S, Voladri DR, Kennedy JL
    Beyond respiratory syncytial virus and rhinovirus: The other viral respiratory bandits.
    Ann Allergy Asthma Immunol. 2025;135:249-260.
    >> Share

    August 2025
  10. PATERSON F, On JY, Ahmed D, Poto R, et al
    Real-life evaluation of novel forced expiratory ratios with asthma exacerbations and symptoms.
    Ann Allergy Asthma Immunol. 2025 Aug 29:S1081-1206(25)00440.
    >> Share

  11. GHABOUSIAN A, Bezerra GN, Zhu Z, Espinola JA, et al
    Impact of varying childhood asthma definitions on incidence and clinical outcomes.
    Ann Allergy Asthma Immunol. 2025 Aug 14:S1081-1206(25)00414.
    >> Share

  12. KHEZRIAN M, Kerkhof M, Le TT, Harrison T, et al
    Adherence to inhaled corticosteroid medications following an asthma exacerbation and the risk of subsequent exacerbations.
    Ann Allergy Asthma Immunol. 2025 Aug 13:S1081-1206(25)00416.
    >> Share

    July 2025
  13. GALLETTA F, Passanisi S, Randazzese SF, Licari A, et al
    Real-Life Evaluation of Biologics in Pediatric Severe Asthma Using Core Outcome Measures for Severe Asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 31:S1081-1206(25)00395.
    >> Share

  14. GREIG R, Chan R, Lipworth B
    Type 2 biomarkers and airway hyper-responsiveness disconnect in uncontrolled severe asthma patients taking benralizumab or dupilumab.
    Ann Allergy Asthma Immunol. 2025 Jul 26:S1081-1206(25)00379.
    >> Share

  15. CORONEL AC, Sanchez-Tamay NM, Ballena-Caicedo J, Zuzunaga-Montoya FE, et al
    Prevalence of asthma in adults in Latin America: a systematic review and meta-analysis.
    Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00375.
    >> Share

  16. ONGTENGCO A, Wilt E, Hardy P, Youssef C, et al
    "Getting in and doing it personally": Engagement Strategies for Rural School Asthma Programs.
    Ann Allergy Asthma Immunol. 2025 Jul 24:S1081-1206(25)00377.
    >> Share

  17. MENDOZA LE, Casilang CG, Morphew T, Barrows J, et al
    Feasibility of Remote Patient Monitoring to Increase Inhaled Corticosteroid Adherence in Children with High-Risk Asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 23:S1081-1206(25)00369.
    >> Share

  18. KAZANCIOGLU A, Ozdemiral C, Cetinkaya PG, Ocak M, et al
    Long-term risk of allergic diseases following allergic proctocolitis: A clinical perspective.
    Ann Allergy Asthma Immunol. 2025 Jul 21:S1081-1206(25)00371.
    >> Share

  19. CHIPPS BE, Panettieri RA Jr, Skolnik N, Cappelletti C, et al
    Albuterol-budesonide rescue inhaler for asthma: patterns of use and safety in the MANDALA trial.
    Ann Allergy Asthma Immunol. 2025 Jul 13:S1081-1206(25)00348.
    >> Share

  20. BUSSE WW
    Oh Eosinophil, what can you tell us about asthma?
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00347.
    >> Share

  21. COTE A, Beach J, Reynolds J, Usuba K, et al
    ALERT (ChAracterizing uncontroLled sevERe asThma in Canada): oral corticosteroid and short-acting beta(2)-agonist overuse.
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00346.
    >> Share

  22. MAHMOOD LZ, Perry TT, Jefferson AA, Berlinski A, et al
    Implications of removing race from spirometry reference equations in children with asthma.
    Ann Allergy Asthma Immunol. 2025 Jul 10:S1081-1206(25)00343.
    >> Share

  23. MISRA G, Grohman R, Kazachkov M, Nowak-Wegrzyn A, et al
    Severe asthma and new-onset meat allergy in a child-could a new puppy be to blame?
    Ann Allergy Asthma Immunol. 2025 Jul 2:S1081-1206(25)00338.
    >> Share

  24. JUBRAN J, Tam JS
    Identifying patients with uncontrolled asthma or severe asthma: Does terminology matter?
    Ann Allergy Asthma Immunol. 2025;135:13-14.
    >> Share

  25. NGO SY, Anderson WC 3rd
    Weighing real-world studies when choosing a biologic for asthma: Insights and pitfalls.
    Ann Allergy Asthma Immunol. 2025;135:11-12.
    >> Share

    June 2025
  26. YE Z, Harrar SW, Beyene J, Mersha TB, et al
    Incorporating Type-2 inflammation status with clinical diagnosis and transcriptomics data in asthma risk classification.
    Ann Allergy Asthma Immunol. 2025 Jun 26:S1081-1206(25)00321.
    >> Share

  27. OMAR W, Hardy P, Pappalardo AA
    National Asthma Control Program: Funding Simple, Effective Strategies to Reduce Asthma Burden and Costs.
    Ann Allergy Asthma Immunol. 2025 Jun 22:S1081-1206(25)00319.
    >> Share

  28. PALLER AS, Soong W, Boguniewicz M, Geng B, et al
    Effect of tralokinumab on moderate-to-severe atopic dermatitis in patients with atopic comorbidities.
    Ann Allergy Asthma Immunol. 2025 Jun 22:S1081-1206(25)00315.
    >> Share

  29. AYACHE M, Khalid F
    Increased Likelihood of COVID-19-Related Asthma Exacerbation with Higher Eosinophil Count.
    Ann Allergy Asthma Immunol. 2025 Jun 21:S1081-1206(25)00316.
    >> Share

  30. HAMADA Y, Thomas D, McDonald VM, Harvey ES, et al
    Impact of clinical remission on quality of life in severe eosinophilic asthma treated with mepolizumab.
    Ann Allergy Asthma Immunol. 2025 Jun 20:S1081-1206(25)00309.
    >> Share

  31. RAYNER DG, Bakaa L, Hoyte F, Perry TT, et al
    Triple therapy versus dual inhaler therapy for moderate-to-severe asthma: an updated systematic review and meta-analysis.
    Ann Allergy Asthma Immunol. 2025 Jun 12:S1081-1206(25)00287.
    >> Share

  32. HENAO MP, Malerich J, George DR
    Impact of Language Barriers on Pulmonary Function and Asthma Control.
    Ann Allergy Asthma Immunol. 2025 Jun 8:S1081-1206(25)00278.
    >> Share

  33. WU Y, Xu W
    Refining asthma disparity research: A call for multidimensional assessment of Aspergillus fumigatus sensitization.
    Ann Allergy Asthma Immunol. 2025;134:739-740.
    >> Share

  34. SALMON MK, Arya P, Backer V, Aanaes K, et al
    Psychometric validation of the Standard Tests for Asthma, Allergic Rhinitis, and Chronic Rhinosinusitis in the United States.
    Ann Allergy Asthma Immunol. 2025;134:671-675.
    >> Share

  35. HAN JK, Silver J, Dhangar I, Veeranki P, et al
    Quantifying corticosteroid burden in chronic rhinosinusitis with nasal polyps: A retrospective US database study.
    Ann Allergy Asthma Immunol. 2025;134:685-693.
    >> Share

    May 2025
  36. HAZLITT R, Nguyen K, Wilson A, Clark P, et al
    Diversity, Equity, and Inclusion in Asthma Clinical Trials: A Cross-Sectional Analysis.
    Ann Allergy Asthma Immunol. 2025 May 27:S1081-1206(25)00267.
    >> Share

  37. MA R, Zhang C, Zhang Y, Tan H, et al
    The Impact of Respiratory Syncytial Virus on Asthma Development and Exacerbation.
    Ann Allergy Asthma Immunol. 2025 May 17:S1081-1206(25)00236.
    >> Share

  38. PUPPELS GJ, Hourihane JO, Nico C, Chaoimh CN, et al
    Erratum to 'Highly accurate, noninvasive early identification of infants with a filaggrin loss-of-function mutation by in vivo Raman spectroscopy, followed from birth to 12 months' [Annals of Allergy, Asthma & Immunology, 134;4 (2025) 457-464].
    Ann Allergy Asthma Immunol. 2025 May 17:S1081-1206(25)00220.
    >> Share

  39. KIM Y, Moonie S, Kim I, Yoo JW, et al
    Increasing trend in asthma hospitalization among cannabis-dependent abusers and recreational cannabis legalizations (1998-2021).
    Ann Allergy Asthma Immunol. 2025 May 11:S1081-1206(25)00232.
    >> Share

  40. NARLA S, Silverberg JI
    Current updates in the epidemiology and comorbidities of atopic dermatitis.
    Ann Allergy Asthma Immunol. 2025 May 9:S1081-1206(25)00228.
    >> Share

  41. DOWLING TC, Shah MM, Moulia DL, Hsu J, et al
    Recommended immunizations to reduce respiratory morbidity and mortality among US adults with asthma, by age.
    Ann Allergy Asthma Immunol. 2025;134:535-538.
    >> Share

  42. MURAI Y, Koya T, Koda H, Uji W, et al
    Dupilumab efficacy in relation to changes in club cell secretory protein 16.
    Ann Allergy Asthma Immunol. 2025;134:556-562.
    >> Share

    April 2025
  43. NGUYEN VT, Roth K, Engelhardt E, Pearlstein A, et al
    The usual suspects: Respiratory Syncytial Virus and Rhinovirus drive asthma development and exacerbation.
    Ann Allergy Asthma Immunol. 2025 Apr 24:S1081-1206(25)00205.
    >> Share

  44. SCOTT EA, Balasubramanian A, Brems JH, Wu TD, et al
    Peripheral eosinophil count as a biomarker for asthma exacerbation severity in acute care settings.
    Ann Allergy Asthma Immunol. 2025 Apr 18:S1081-1206(25)00183.
    >> Share

  45. SCURLOCK AM, Fleischer DM, Toit GD, Arends NJT, et al
    Efficacy and Safety of Epicutaneous Immunotherapy in Peanut-allergic Children with Atopic Comorbidities.
    Ann Allergy Asthma Immunol. 2025 Apr 7:S1081-1206(25)00179.
    >> Share

  46. GARDNER DD, Gokani R, Hey-Hadavi J, Williams D, et al
    Healthcare-Seeking Behaviors for Acute Asthma: A US Cross-sectional Survey.
    Ann Allergy Asthma Immunol. 2025 Apr 3:S1081-1206(25)00175.
    >> Share

  47. GRAYSON MH
    Asthma and evolving trends in allergy and immunology.
    Ann Allergy Asthma Immunol. 2025;134:369.
    >> Share

    March 2025
  48. KALRA S, Kalra D, Nagaraja N, Hlaing WM, et al
    Food Allergy and Asthma in a Nationally Representative Sample of Adolescents in the United States.
    Ann Allergy Asthma Immunol. 2025 Mar 28:S1081-1206(25)00152.
    >> Share

  49. TO M, Arimoto Y, Honda N, Furusho N, et al
    Elevated oxidative stress and steroid insensitivity in patients with asthma and high body fat percentage.
    Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00126.
    >> Share

  50. FAN H, Ren Z, Zhang P, Zhou B, et al
    Increased asthma burden during and post the COVID-19 pandemic among U.S. adults.
    Ann Allergy Asthma Immunol. 2025 Mar 15:S1081-1206(25)00123.
    >> Share

  51. VIINANEN A, Ilmarinen P, Mehtala J, Jylhava J, et al
    Factors associated with the development of severe asthma - a nationwide study (FINASTHMA).
    Ann Allergy Asthma Immunol. 2025 Mar 9:S1081-1206(25)00119.
    >> Share

  52. GELB AF, Tashkin DP
    Utility of using thoracic computed tomography to measure lung function decline and detect unsuspected emphysema in severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:253-254.
    >> Share

  53. TANABE N
    Further evidence for the roles of computed tomography in managing severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:251-252.
    >> Share

  54. MATHUR SK, Silver J, MacKnight SD, Urosevic A, et al
    Real-world mepolizumab treatment in eosinophilic granulomatosis with polyangiitis reduces disease burden in the United States.
    Ann Allergy Asthma Immunol. 2025;134:341-350.
    >> Share

    February 2025
  55. LUGOGO NL, Gilbert IA, Gandhi HN, Tkacz JP, et al
    Exacerbation burden in patients treated as intermittent or mild-persistent asthma using short-acting beta(2)-agonist rescue.
    Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00088.
    >> Share

  56. SKEEN E, Hamlington KL, De Keyser H, Liu AH, et al
    Managing Childhood Asthma with an Eye Toward Environmental, Social and Behavioral Features.
    Ann Allergy Asthma Immunol. 2025 Feb 24:S1081-1206(25)00092.
    >> Share

  57. CEGOLON L, Filon FL, Lange JH
    Social determinants of health, Black race, sensitization to indoor molds and risk of severe asthma.
    Ann Allergy Asthma Immunol. 2025;134:125-126.
    >> Share

  58. GALANT SP
    Oscillometry-determined small airway dysfunction as a significant risk for poor asthma control and exacerbations.
    Ann Allergy Asthma Immunol. 2025;134:123-124.
    >> Share

    January 2025
  59. BRUZZESE JM, Cespedes A, Ainapudi V, Kingston S, et al
    Barriers to Seeing a Healthcare Provider among Rural Adolescents with Poorly Controlled Asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00046.
    >> Share

  60. GREIG R, Chan R, Fardon TC, Lipworth BJ, et al
    Real world effects of tezepelumab on small airways dysfunction in severe refectory asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 25:S1081-1206(25)00064.
    >> Share

  61. COTTINI M, Ventura L, Lombardi C, Landi M, et al
    Small airway dysfunction mediates the relationship between FeNO and asthma control.
    Ann Allergy Asthma Immunol. 2025 Jan 16:S1081-1206(25)00004.
    >> Share

  62. LEE JK, Pollard SJ, Liu MC, Schleich F, et al
    Mepolizumab real-world effectiveness in severe asthma with an eosinophilic phenotype and overlapping severe allergic asthma.
    Ann Allergy Asthma Immunol. 2025 Jan 11:S1081-1206(25)00003.
    >> Share

  63. OPPENHEIMER J, Casale T
    Care of asthma-a rapidly moving story.
    Ann Allergy Asthma Immunol. 2025;134:1-2.
    >> Share

    December 2024
  64. MILIGKOS M, Oh J, Kwon R, Konstantinou GNu, et al
    Epidemiology of asthma across the ages.
    Ann Allergy Asthma Immunol. 2024 Dec 12:S1081-1206(24)01727.
    >> Share

  65. ELLIOTT MR, O'Connor AE, Marshall GD
    Corrigendum to 'Inflammatory pathways in patients with post-acute sequelae of COVID-19' [Annals of Allergy, Asthma & Immunology 133/5 (2024) 507 - 515].
    Ann Allergy Asthma Immunol. 2024 Dec 7:S1081-1206(24)01716.
    >> Share

  66. OU MC, Tsai RY, Li CP, Gau SY, et al
    Real-world effectiveness of mepolizumab in patients with asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024;133:732-733.
    >> Share

  67. CHAN R, Kuo CR, Fardon T, Thouseef MJ, et al
    The interplay between skeletal muscle adiposity and radiographic features of airway remodeling in persistent asthma.
    Ann Allergy Asthma Immunol. 2024;133:626-627.
    >> Share

    November 2024
  68. ZHANG B, Yan M, Li C, Zhao J, et al
    Impact of asthma severity on surgical outcomes in patients with chronic rhinosinusitis comorbid with asthma.
    Ann Allergy Asthma Immunol. 2024 Nov 29:S1081-1206(24)01712.
    >> Share

  69. LANZ MJ, Chipps B, Zeiger RS, Bacharier LB, et al
    Pediatric Asthma Impairment and Risk Questionnaire: Rationale and Development of a Composite Control Tool.
    Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01711.
    >> Share

  70. CONWAY AE, Marshall GD, Oppenheimer J, Shaker MS, et al
    Should Biologics Be Available for All Patients with Uncontrolled Asthma, Regardless? Absolutely and Here's Why.
    Ann Allergy Asthma Immunol. 2024 Nov 28:S1081-1206(24)01713.
    >> Share

  71. GREIMANN E, Freigeh GE, Wettenstein RP, Nelson B, et al
    Mild Asthma- What Matters to Patients and Parents.
    Ann Allergy Asthma Immunol. 2024 Nov 26:S1081-1206(24)01708.
    >> Share

  72. DUCHARME FM, Chan R
    Oscillometry in the diagnosis, assessment, and monitoring of asthma in children and adults: review article.
    Ann Allergy Asthma Immunol. 2024 Nov 25:S1081-1206(24)01702.
    >> Share

  73. GOCHICOA-RANGEL L, Vargas MH
    How best to choose an oscillometer and reference equations for your patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Nov 16:S1081-1206(24)01681.
    >> Share

  74. COTTINI M, Lombardi C, Comberiati P, Berti A, et al
    Oscillometry-defined small airways dysfunction as a treatable trait in asthma.
    Ann Allergy Asthma Immunol. 2024 Nov 15:S1081-1206(24)01658.
    >> Share

  75. ZHANG W, Li L, Zhang Y, Dai J, et al
    Perturbations in the airway microbiome are associated with type 2 asthma phenotype and severity.
    Ann Allergy Asthma Immunol. 2024 Nov 14:S1081-1206(24)01657.
    >> Share

  76. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
    Corrigendum to <'A systematic review and expert Delphi Consensus recommendation on the use of vaccines in patients receiving dupilumab: A position paper of the American College of Allergy, Asthma and Immunology'> <[Annals of Allergy, Asthma & Immunolo
    Ann Allergy Asthma Immunol. 2024 Nov 2:S1081-1206(24)01630.
    >> Share

  77. YU JT, Gau SY, Li CP, Chang HC, et al
    Real-world association between cat ownership and asthma.
    Ann Allergy Asthma Immunol. 2024;133:613.
    >> Share

  78. SHEN CY, Li CP, Tsai RY, Chang HC, et al
    Infant urinary adrenal steroids and childhood asthma development.
    Ann Allergy Asthma Immunol. 2024;133:611-612.
    >> Share

  79. GRAYSON MH
    The future of allergy and immunology research: 2024 American College of Allergy, Asthma and Immunology Annals Fellow-in-Training award winners.
    Ann Allergy Asthma Immunol. 2024;133:505-506.
    >> Share

  80. ESCHENBACHER WH
    Treatment of type 2 inflammation: Targeted therapy for chronic rhinosinusitis with nasal polyps and asthma.
    Ann Allergy Asthma Immunol. 2024;133:497-498.
    >> Share

    October 2024
  81. RAO R, Han YY, Valentin-Rodriguez LA, Presto AA, et al
    Proximity to Fast-Food Restaurants and Pediatric Asthma Outcomes.
    Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01631.
    >> Share

  82. RUPPRECHT C, Krishnaswamy G
    OSTEONECROSIS: A DISABLING DISEASE NOT TO BE IGNORED IN ASTHMA AND ATOPIC CONDITIONS.
    Ann Allergy Asthma Immunol. 2024 Oct 26:S1081-1206(24)01632.
    >> Share

  83. GALLEGOS-KOYNER FJ, Hodo F, Barrera NI, Cerrud-Rodriguez RC, et al
    Opioid Use Disorder's Impact on Asthma Hospitalizations: A Propensity Matched Nationwide Study.
    Ann Allergy Asthma Immunol. 2024 Oct 18:S1081-1206(24)01577.
    >> Share

  84. MANKA LA, Guntur VP, Stevens AD, Kolakowski C, et al
    The Supraglottic Index: An Indicator of Response to Laryngopharyngeal Reflux Therapy in Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 15:S1081-1206(24)01573.
    >> Share

  85. ZIDAN E, Wilson G, Shin JJ, Chupp G, et al
    The Next Frontier: Defining and Optimizing Treatments for Patients with T2 Low Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 14:S1081-1206(24)01571.
    >> Share

  86. SELUK L, Davis AE, Rhoads S, Wechsler ME, et al
    Novel asthma treatments: Advancing Beyond Approved Novel Step-Up Therapies for Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 9:S1081-1206(24)01552.
    >> Share

  87. MAILHOT-LAROUCHE S, Celis-Preciado C, Heaney LG, Couillard S, et al
    Identifying Super-Responders: a Review of the Road to Asthma Remission.
    Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01559.
    >> Share

  88. GREIG R, Stewart K, Chan R, Lipworth B, et al
    Assessment of bronchodilator responsiveness using low frequency impedance in type 2 high uncontrolled severe asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01570.
    >> Share

  89. BUSSE WW
    The Role of Biologics in Inducing Remission in Asthma.
    Ann Allergy Asthma Immunol. 2024 Oct 7:S1081-1206(24)01557.
    >> Share

  90. MIYATA Y, Tanaka A, Ebato T, Kashima A, et al
    Baseline forced oscillation technique predicting lack of exacerbations in adult with asthma: A 12-month prospective.
    Ann Allergy Asthma Immunol. 2024 Oct 4:S1081-1206(24)01553.
    >> Share

  91. WEINBERGER MM, Hendeles L
    Biologics for asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024;133:356-357.
    >> Share

  92. CORELLI ER, Peebles RS Jr
    Race toward more equitable pulmonary function testing?
    Ann Allergy Asthma Immunol. 2024;133:362-363.
    >> Share

  93. MCCULLOCH MR, Bothwell S, Brinton JT, Anderson WC 3rd, et al
    Effect of electronic medication monitoring on asthma outcomes in a multidisciplinary pediatric severe asthma clinic.
    Ann Allergy Asthma Immunol. 2024 Oct 1:S1081-1206(24)01533.
    >> Share

    September 2024
  94. BLOODWORTH MH, Staso PJ, Huang S, Farber-Eger E, et al
    Metabolic and weight components' impact on incident asthma using a real-world cohort.
    Ann Allergy Asthma Immunol. 2024 Sep 16:S1081-1206(24)01509.
    >> Share

  95. CHAN R, Lipworth B
    Airway oscillometry in asthma - present and future perspectives.
    Ann Allergy Asthma Immunol. 2024 Sep 14:S1081-1206(24)01529.
    >> Share

  96. GLEESON PK, Morales KH, Kerlin MP, Fadugba OO, et al
    Asthma exacerbations in Aspergillus fumigatus-sensitized adults with asthma differs by race.
    Ann Allergy Asthma Immunol. 2024 Sep 9:S1081-1206(24)01504.
    >> Share

  97. SIM DW, Choi S, Jeong J, Lee SY, et al
    Computed tomography-based measurements associated with rapid lung function decline in severe asthma.
    Ann Allergy Asthma Immunol. 2024 Sep 5:S1081-1206(24)01502.
    >> Share

  98. KAIDASHEV I, Ditiatkovskaya E
    Managing Asthma and Allergies during the Russo-Ukrainian War.
    Ann Allergy Asthma Immunol. 2024 Sep 3:S1081-1206(24)00573.
    >> Share

  99. SHAMIM J
    The relationship of height and asthma.
    Ann Allergy Asthma Immunol. 2024;133:352.
    >> Share

  100. PHILIPENKO BS, Davis B, Cockcroft DW
    To stop or not to stop an asthma biologic, that is the question.
    Ann Allergy Asthma Immunol. 2024;133:236-237.
    >> Share

  101. BRIGHTLING CE, Caminati M, Llanos JP, Caveney S, et al
    Biomarkers and clinical outcomes after tezepelumab cessation: Extended follow-up from the 2-year DESTINATION study.
    Ann Allergy Asthma Immunol. 2024;133:310-317.
    >> Share

    August 2024
  102. HAYASHI Y, Tanabe N, Shimizu K, Maetani T, et al
    Lower skeletal muscle density and airway structure on computed tomography in asthma (12/15 words).
    Ann Allergy Asthma Immunol. 2024 Aug 21:S1081-1206(24)00527.
    >> Share

  103. HAGWOOD SR, Elliott M, Marshall GD
    Comparing Prevalence of Food Allergy in Exercise-induced Bronchoconstriction vs. Asthma.
    Ann Allergy Asthma Immunol. 2024 Aug 13:S1081-1206(24)00496.
    >> Share

  104. ROTBLAT D, Wei C, Reyna GC, Grabie Y, et al
    Impact of Cannabinoid Use on Acute Pulmonary Outcomes in Hospitalized Asthmatic Patients.
    Ann Allergy Asthma Immunol. 2024 Aug 3:S1081-1206(24)00486.
    >> Share

  105. MALDONADO-PUEBLA M, Ledford D, Cardet JC
    The minimal clinically important difference in the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024;133:123-124.
    >> Share

  106. STEWART K, Kuo CR, Chan R, Lipworth B, et al
    Evaluating an electronic device to monitor the type 2 high unified airway response to dupilumab.
    Ann Allergy Asthma Immunol. 2024;133:211-213.
    >> Share

    July 2024
  107. SOTO-RETES L, Milagro J, Crespo-Lessmann A, Curto E, et al
    Parasympathetic nervous system: a key role in control and mood disorders in patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00480.
    >> Share

  108. FITZPATRICK AM, Mohammad AF, Desher K, Mutic AD, et al
    Clinical and inflammatory features of traffic-related diesel exposure in children with asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 27:S1081-1206(24)00457.
    >> Share

  109. HAN YY, Celedon JC
    The Effects of Violence and Related Stress on Asthma.
    Ann Allergy Asthma Immunol. 2024 Jul 26:S1081-1206(24)00479.
    >> Share

  110. FRUEH L, Sharma R, Sheffield PE, Clougherty JE, et al
    Community Violence and Asthma: A Review.
    Ann Allergy Asthma Immunol. 2024 Jul 20:S1081-1206(24)00453.
    >> Share

  111. CHIARELLA SE, Garcia-Guaqueta DP, Drake LY, Dixon RE, et al
    Sex differences in sociodemographic, clinical, and laboratory variables in childhood asthma: A birth cohort study.
    Ann Allergy Asthma Immunol. 2024 Jul 15:S1081-1206(24)00426.
    >> Share

  112. TAJIRI T, Suzuki M, Nishiyama H, Ozawa Y, et al
    Efficacy of dupilumab for severe chronic rhinosinusitis with nasal polyps and asthma: A prospective study.
    Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00422.
    >> Share

  113. BERNSTEIN JA, Silver J, Packnett E, Lew CR, et al
    Real-world unified airway benefits of mepolizumab: effectiveness in patients with asthma and comorbid nasal polyps.
    Ann Allergy Asthma Immunol. 2024 Jul 5:S1081-1206(24)00421.
    >> Share

  114. SIM S, Jang JH, Park HS
    Contribution of non-neuronal cholinergic system to T2-low airway inflammation in severe asthma.
    Ann Allergy Asthma Immunol. 2024;133:7-8.
    >> Share

  115. GUTIERREZ CG, Bukstein DA
    Functionality of the Asthma Impairment and Risk Questionnaire and its implications in shared decision-making.
    Ann Allergy Asthma Immunol. 2024;133:5-6.
    >> Share

  116. HARRIS D, Borish L
    How we treat type 2 low asthma.
    Ann Allergy Asthma Immunol. 2024;133:43-46.
    >> Share

  117. MULLUR J, Buchheit KM
    Correction to "Aspirin-exacerbated respiratory disease" by Mullur J and Buchheit KM (Ann Allergy Asthma Immunol 131 (2023) 317-324).
    Ann Allergy Asthma Immunol. 2024;133:118.
    >> Share

  118. CONWAY AE, White AA, Borish L, Shaker M, et al
    Eicosanoids, innate immunity, and alarmins in aspirin-exacerbated respiratory disease.
    Ann Allergy Asthma Immunol. 2024;133:13-15.
    >> Share

    June 2024
  119. TRASANDE L
    The Role of Plastics in Allergy, Immunology and Human Health: What the Clinician Needs to Know and Can Do About It.
    Ann Allergy Asthma Immunol. 2024 Jun 28:S1081-1206(24)00417.
    >> Share

  120. ADELEKE S, Ongtengco A, Youssef C, Hardy P, et al
    Addressing Critical Barriers for Sustainability of Asthma Stock Inhaler Policy Implementation and Resultant Programming.
    Ann Allergy Asthma Immunol. 2024 Jun 26:S1081-1206(24)00373.
    >> Share

  121. BAREILLE P, Forth R, Imber V, Bondarenko I, et al
    Once-Daily Fluticasone Furoate/Vilanterol Versus Once-Daily Fluticasone Furoate in Asthma Patients Aged 5-17 Years.
    Ann Allergy Asthma Immunol. 2024 Jun 25:S1081-1206(24)00376.
    >> Share

  122. MISHRA PE, Han YY, Hill K, Rosser FJ, et al
    Persistent cat ownership and asthma in a longitudinal study of Puerto Rican youth.
    Ann Allergy Asthma Immunol. 2024 Jun 24:S1081-1206(24)00375.
    >> Share

  123. ZAEH SE, Zimmerman ZE, Eakin MN, Chupp G, et al
    Adoption and Implementation of Maintenance and Reliever Therapy for Adults with Moderate to Severe Asthma.
    Ann Allergy Asthma Immunol. 2024 Jun 17:S1081-1206(24)00363.
    >> Share

  124. ZEIGER JS, Silvers WS, Zeiger RS
    Comparison of Cannabis Knowledge, Attitudes, and Practice (KAP) between Allergists and Allergic and Asthmatic Patients.
    Ann Allergy Asthma Immunol. 2024 Jun 13:S1081-1206(24)00347.
    >> Share

  125. LIEBERMAN JA, Chu DK, Ahmed T, Dribin TE, et al
    Use of Vaccines in Patients Receiving Dupilumab, A Systematic Review and Expert Delphi Consensus Recommendation: A position paper of the American College of Allergy, Asthma and Immunology.
    Ann Allergy Asthma Immunol. 2024 Jun 5:S1081-1206(24)00337.
    >> Share

  126. SEDAGHAT AR, Phillips KM
    Unifying the airway through multiomics.
    Ann Allergy Asthma Immunol. 2024;132:667-668.
    >> Share

    May 2024
  127. BELLANTI JA, Settipane RA
    Legacy of Congressman George Miller O'Brien: Advocate for the patient with asthma and allergic disease.
    Ann Allergy Asthma Immunol. 2024 May 31:S1081-1206(24)00308.
    >> Share

  128. PETERSEN M, Bingemann TA
    Correction to "Navigating allergic disease in military accessions: A crucial role for civilian allergists" (Ann Allergy Asthma Immunol 132 (2024) 547-548).
    Ann Allergy Asthma Immunol. 2024 May 18:S1081-1206(24)00285.
    >> Share

  129. CHUPP G, Murphy KR, Gandhi HN, Gilbert I, et al
    Asthma control in the United States: relationships between short-acting beta(2)-agonist and systemic corticosteroid use.
    Ann Allergy Asthma Immunol. 2024 May 11:S1081-1206(24)00287.
    >> Share

  130. KLOEPFER KM, Kennedy JL
    Decoding viral infections and risk for asthma: Biomarkers or clinical histories?
    Ann Allergy Asthma Immunol. 2024;132:553-554.
    >> Share

  131. KATIAL RK, Hoyte FCL
    Comment on geographic variation in disease burden among patients with severe persistent asthma in the United States.
    Ann Allergy Asthma Immunol. 2024;132:551-552.
    >> Share

    April 2024
  132. TURI KN, Li Y, Xu Y, Gebretsadik T, et al
    The Association of Infant Urinary Adrenal Steroids with the Risk of Childhood Asthma Development.
    Ann Allergy Asthma Immunol. 2024 Apr 15:S1081-1206(24)00215.
    >> Share

  133. WOO SD, Park HS, Yang EM, Ban GY, et al
    8-Iso-prostaglandin F2alpha as a biomarker of T2-low airway inflammation and remodeling in adult asthma.
    Ann Allergy Asthma Immunol. 2024 Apr 12:S1081-1206(24)00214.
    >> Share

    March 2024
  134. MOTA D, Martins C, Puga N, Moreira A, et al
    Asthma and allergy screening in elite football athletes: is it worth it?
    Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00205.
    >> Share

  135. LEE PH, An M, Hwang D, Jang AS, et al
    Impact of circulating angiomotin and angiostatin on clinical variables in patients with asthma.
    Ann Allergy Asthma Immunol. 2024 Mar 29:S1081-1206(24)00207.
    >> Share

  136. HUANG D, Zhang L, Liu Y, Wang J, et al
    Activated non-neuronal cholinergic system correlates with non-type 2 inflammation and exacerbations in severe asthma.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00150.
    >> Share

  137. ZAHRAEI HN, Schleich F, Louis G, Gerday S, et al
    Evidence for two clusters among non-eosinophilic asthmatics.
    Ann Allergy Asthma Immunol. 2024 Mar 16:S1081-1206(24)00154.
    >> Share

  138. CHIPPS BE, Zeiger RS, Beuther DA, Wise RA, et al
    Advancing assessment of asthma control with a composite tool: the Asthma Impairment and Risk Questionnaire.
    Ann Allergy Asthma Immunol. 2024 Mar 15:S1081-1206(24)00153.
    >> Share

  139. LI Y, Hong X, Chandran A, Keet CA, et al
    Associations between cord blood acetaminophen biomarkers and childhood asthma with and without allergic comorbidities.
    Ann Allergy Asthma Immunol. 2024 Mar 12:S1081-1206(24)00143.
    >> Share

  140. GWAK DY, Tea JC, Fatima FN, Palka JM, et al
    Contribution of caregiver and child anxiety and depressive symptoms to child asthma-related quality of life.
    Ann Allergy Asthma Immunol. 2024 Mar 6:S1081-1206(24)00141.
    >> Share

    February 2024
  141. CETIN GP, Yilmaz I
    What should be the outcome of biological treatment in asthma: "Remission on Treatment" or "Super-responder".
    Ann Allergy Asthma Immunol. 2024 Feb 23:S1081-1206(24)00103.
    >> Share

  142. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
    Lower paraspinal muscle density is associated with small airway dysfunction in women with persistent asthma.
    Ann Allergy Asthma Immunol. 2024 Feb 22:S1081-1206(24)00089.
    >> Share

    January 2024
  143. CHEN C, Song X, Murdock DJ, Marcus A, et al
    Association between allergic conditions and COVID-19 susceptibility and outcomes.
    Ann Allergy Asthma Immunol. 2024 Jan 17:S1081-1206(24)00011.
    >> Share

    November 2023
  144. KIM BE, Hui-Beckman JW, Nevid MZ, Goleva E, et al
    Air pollutants contribute to epithelial barrier dysfunction and allergic diseases.
    Ann Allergy Asthma Immunol. 2023 Nov 23:S1081-1206(23)01462.
    >> Share

  145. GEVAERT P, Mullol J, Saenz R, Ko J, et al
    Omalizumab improves sinonasal outcomes in patients with chronic rhinosinusitis with nasal polyps regardless of allergic status.
    Ann Allergy Asthma Immunol. 2023 Nov 9:S1081-1206(23)01393.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016